US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Celyad Oncology SA (0QFK) 銘柄情報

Celyad Oncology SA (0QFK)

18.94

0.00

(0.00%)

終了 7月12日 12:30AM

Celyad Oncology SA (0QFK) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

18.94

( - )

買値

18.47

売値

19.41

出来高

0.00

平均取引量 (3 か月)

15,066 €

財務取引量

-

0.00 日の範囲 0.00

18.94 52 週間の範囲 18.94

時価総額

企業価値

8.811M

前日終値

18.94

始値

-

時刻

最終取引時間

VWAP

-

歳入

21k

純利益

830k

発行済株式数

44,761,905

浮動株比率 (%)

31.61%

機関投資家保有比率 (%)

58.62%

配当利回り

PER

13.06

株価売上高倍率 (PSR)

500.91

1 株当たり利益 (EPS)

0.02

ベータ

1.21

Celyad Oncology SA, a biotechnology company, focuses on unlocking the potential of its intellectual property. Its portfolio comprises multiple foundational US patents focused on TCR-deficient T cell compositions, and it broadly covers allogeneic CAR T cell therapies. The company was formerly known a... Celyad Oncology SA, a biotechnology company, focuses on unlocking the potential of its intellectual property. Its portfolio comprises multiple foundational US patents focused on TCR-deficient T cell compositions, and it broadly covers allogeneic CAR T cell therapies. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium. 詳細を表示

セクター

Health Care

業界

-

ウェブサイト

celyad.com

本社

Mont-saint-guibert, Belgium

設立

2026

Celyad Oncology SA is listed in the Health Care sector of the ロンドン証券取引所 with ticker 0QFK. The last closing price for Celyad Oncology was 18.94 €. Over the last year, Celyad Oncology shares have traded in a share price range of 18.94 € to 18.94 €.

Celyad Oncology currently has 44,761,905 shares in issue. The market capitalisation of Celyad Oncology is 847.79 € million. Celyad Oncology has a price to earnings ratio (PE ratio) of 13.06.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	18.94	18.94	18.94	1349	18.94	DE
52	0	0	18.94	18.94	18.94	696	18.94	DE
156	0	0	18.94	18.94	18.94	349	18.94	DE
260	0	0	18.94	18.94	18.94	788	18.94	DE

0QFK - Frequently Asked Questions (FAQ)

What is the current Celyad Oncology SA share price?

The current share price of Celyad Oncology SA is 18.94 €

How many Celyad Oncology SA shares are in issue?

Celyad Oncology SA has 44,761,905 shares in issue

What is the market cap of Celyad Oncology SA?

The market capitalisation of Celyad Oncology SA is EUR 847.79M

What is the 1 year trading range for Celyad Oncology SA share price?

Celyad Oncology SA has traded in the range of 18.94 € to 18.94 € during the past year

What is the PE ratio of Celyad Oncology SA?

The price to earnings ratio of Celyad Oncology SA is 13.06

What is the cash to sales ratio of Celyad Oncology SA?

The cash to sales ratio of Celyad Oncology SA is 500.91

What is the registered address of Celyad Oncology SA?

The registered address for Celyad Oncology SA is Axis Business Park, Mont-Saint-Guibert, Walloon Brabant, 1435

What is the Celyad Oncology SA website address?

The website address for Celyad Oncology SA is celyad.com

ListenToTheTrees

ListenToTheTrees 6分前

That is a false choice.

Business outcomes are not limited to only two explanations: incompetence or fraud. Deals can fail because of financing constraints, market conditions, regulatory issues, integration problems, changing strategy, partner failures, execution mistakes, or assumptio

waterchaser

waterchaser 7分前

Yet HIRU is still basically WORTHLESS.
Some things never change on the scam OTC.

Newtogame

Newtogame 9分前

Tazzie 5-22-12-7 Moose 12-9-7-2 Chance 12-5-2-48 New 12-2-7-9
GLTA

layton

I’ve seen it all and heard it all on these Pink Sheets…..

lakers17

lakers17 10分前

Same lame divy ploy and lame pump. How about an actual PR from the company on this? And most importantly if there is actually a divy will it be restricted as most likely or if not restricted free trading shares? What the whale guy posted said restricted. Company needs to actually PR with the det

TenKay

TenKay 11分前

“The reverse split wasn’t “hidden.” Reverse splits require board approval, regulatory filings, and notice before becoming effective.“

You seem to forget they were not an SEC filer back then. There was no notice or filings. Only when it hit the dailylist with FINRA was it revealed an

Genz2

https://www.flexjobs.com/remote-jobs/company/wave_systems

MightyX

MightyX 12分前

Just play eachother twister already lol seriously.

Lord Andreti

Lord Andreti 13分前

What about him? He’s been there for 2 years+ now. This went dark under him

12yearplan

12yearplan 14分前

Timely news fo sho and bless you and thank you for sharing your first post at the IPub at $FOBI Mr White the 3rd 🙂
$FOBI $FOBIF
https://www.youtube.com/watch?v=gwj7orosB-s

Bill48

Bill48 15分前

Thanks! Gltu and all escrow holders!!

1kgwxman

1kgwxman 16分前

I recall how there was allegedly supposed to be an "investigation" by Texas AG Attorney General Ken Paxton into AMFN
Nithing but...
🦗🦗🦗🦗🦗🦗🦗🦗🦗🦗🦗🦗🦗🦗🦗🦗🦗

Large Green

Large Green 17分前

Class 19 = WAMPQ = $1,000.00 Face Value and WAMKQ = $25.00 Face Value or 1/40th of a single WAMPQ

100lbStriper

100lbStriper 18分前

actually its not. if you read the terms of usage anything posted on ihub becomes ihubs property. so there!!! na na na na na!!!!

ipiros

ipiros 18分前

https://x.com/patalithium/status/2076064958685872575?s=46&t=1mtQtgXmx35-BlWutjUYiQ

ListenToTheTrees

ListenToTheTrees 23分前

You’re taking a series of business decisions, some of which clearly didn’t work out, and presenting them as proof of fraud. That’s a conclusion, not evidence.

The reverse split wasn’t “hidden.” Reverse splits require board approval, regulatory filings, and notice before becoming effec

Bill48

Bill48 24分前

Is the face value for class 19 $10,000. ? Thanks in advance!!

Craig305

Craig305 27分前

They have filed their annual registration on time with the Nevada Business Registration website. Joaquin was added as a Director on their documents. We continue waiting for their annual financials to be released end of August and then hopefully they start the ball rolling with the announced catalys

Large Green

Large Green 28分前

newflow, Gemini also does not address that the legal teams spent almost two years with Judge Walrath, and she finally agreed to dissolve the (APR) Absolute Priority Rule in favor of the 75/25 split, so in the event there was only ten billion (this was Walrath's posit), the commons would be able to p

vein

Way lite on the target !!

Prudent Capitalist

Prudent Capitalist 34分前

I did not delete any posts. Moderators can no longer delete posts.

gdog

Its my pm so shouldn't count ;+)

JoeForkeyBolo

JoeForkeyBolo 35分前

This is my latest backtest of NAIL (Direxion Homebuilders & Supplies 3X ETF) – which I consider one of the best leveraged ETFs to use with AIM due to its high volatility and cyclical nature, assuming the investor can handle the large swings in value.

As previously posted, I am re-perf

laraz5

laraz5 36分前

Tomorrow will mark 60 days since Mike had the T/A gagged and turned the lights off on his loyalist of shareholders?
Excluding Clifford, hes been riding with Michael O'Shea well before Xcelerate Xcelled down a spiral of toxic loss from .12 to .014?
Remember the word for him? "Accredited

Celyad Oncology

US Dollar vs LSL

Northwest Copper (PK)

NMBS SNCB Belgian Railway

UBS MSCI United Kingdom ...

Fukuyama Transporting (PK)

Tisdale Resources

Eqty Lkd Nts 15/10/26

Capitania Office FII Fun...

Hapag Lloyd Aktien (PK)

Germanophone Community B...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。